| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2009 | CA2696488A1 Bicyclic sphingosine 1-phosphate analogs |
| 02/19/2009 | CA2696460A1 Combination motif immune stimulatory oligonucleotides with improved activity |
| 02/19/2009 | CA2696430A1 Quinazolinedione chymase inhibitors |
| 02/19/2009 | CA2696404A1 Therapeutic compounds |
| 02/19/2009 | CA2696349A1 Heterocyclic inhibitors of necroptosis |
| 02/19/2009 | CA2696336A1 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2696335A1 Gel containing pirfenidone |
| 02/19/2009 | CA2696330A1 Novel forms of cddo methyl ester |
| 02/19/2009 | CA2696315A1 Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain |
| 02/19/2009 | CA2696314A1 Therapeutic compounds |
| 02/19/2009 | CA2696310A1 Method of treating disease involving myelin and/or axonal loss |
| 02/19/2009 | CA2696288A1 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2696285A1 Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2696127A1 Dhea compositions for treating menopause |
| 02/19/2009 | CA2696063A1 Immediate release and sustained release ibuprofen dosing form |
| 02/19/2009 | CA2696047A1 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 02/19/2009 | CA2696041A1 Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient |
| 02/19/2009 | CA2696012A1 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 02/19/2009 | CA2696006A1 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | CA2695995A1 Triazole compounds that modulate hsp90 activity |
| 02/19/2009 | CA2695989A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections |
| 02/19/2009 | CA2695984A1 Tricyclic amine compound |
| 02/19/2009 | CA2695977A1 Tricyclic amide compound |
| 02/19/2009 | CA2695971A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 02/19/2009 | CA2695956A1 Substituted hydantoins |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2695759A1 Method for stabilizing phenylephrine |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/19/2009 | CA2695753A1 Compounds useful as protein kinases inhibitors |
| 02/19/2009 | CA2695636A1 Bicyclic acylguanidine derivative |
| 02/19/2009 | CA2695475A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | CA2695456A1 3' substituted compounds having 5-ht6 receptor affinity |
| 02/19/2009 | CA2695251A1 Fused imidazoles for cancer treatment |
| 02/19/2009 | CA2695176A1 Peritoneal dialysate |
| 02/19/2009 | CA2695151A1 Polymer therapy for the treatment of chronic microvascular diseases |
| 02/19/2009 | CA2695088A1 Novel piperazine amide derivatives |
| 02/19/2009 | CA2694993A1 1,2-diamido-ethylene derivatives |
| 02/19/2009 | CA2694973A1 Toll like receptor modulators |
| 02/19/2009 | CA2694836A1 Solid valsartan composition |
| 02/19/2009 | CA2694835A1 Novel crystalline form |
| 02/19/2009 | CA2694666A1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents |
| 02/19/2009 | CA2694497A1 Quaternary opioid carboxamides |
| 02/19/2009 | CA2694209A1 Azepine derivatives as gamma-secretase inhibitors |
| 02/19/2009 | CA2694058A1 Fused bicyclic pyrimidines |
| 02/19/2009 | CA2693162A1 Heterocyclic compounds and uses as anticancer agents |
| 02/19/2009 | CA2693041A1 Antimicrobial parenteral formulation |
| 02/19/2009 | CA2691593A1 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | CA2691586A1 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | CA2687964A1 Treatment of viral infections by modulation of host cell metabolic pathways |
| 02/19/2009 | CA2687332A1 Pyrrolopyridine derivatives and their use as bace inhibitors |
| 02/19/2009 | CA2685605A1 Treatment of duchenne muscular dystrophy |
| 02/19/2009 | CA2685582A1 Treatment of duchenne muscular dystrophy |
| 02/19/2009 | CA2684873A1 Anti-bacterial drug targeting of genome maintenance interfaces |
| 02/19/2009 | CA2683316A1 Anti-angiogenic agents and methods of use |
| 02/19/2009 | CA2681347A1 Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
| 02/19/2009 | CA2680680A1 Modified dosage forms of tacrolimus |
| 02/19/2009 | CA2658681A1 Hyaluronic acid dispersion, production and use |
| 02/18/2009 | EP2025758A1 NOVEL ANTIBIOTICS, BISPOLIDES A1, A2 AND A3 AND BISPOLIDES B1, B2a, B2b AND B3 AND METHOD FOR PRODUCING THE ANTIBIOTICS |
| 02/18/2009 | EP2025757A2 Polymeric immunoglobulin receptor-mediated gene transfer |
| 02/18/2009 | EP2025752A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 02/18/2009 | EP2025687A1 Process for the preparation of heparanase-inhibiting sulfated hyaluronates and products obtained thereby |
| 02/18/2009 | EP2025680A1 Degranulation inhibitor |
| 02/18/2009 | EP2025679A2 [3.2.0] Heterocyclic compounds and methods of using the same |
| 02/18/2009 | EP2025678A1 Pyrazolo[3,4-d]pyrimidine compounds and their use as modulators of protein kinase |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025671A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
| 02/18/2009 | EP2025670A1 3-(Phenyl or quinolyl)thio-1H-indole-1-acetic acid derivatives as modulators of CRTh2 receptor activity |
| 02/18/2009 | EP2025669A1 Alpha-alkyl substituted N-acyltryptophanols |
| 02/18/2009 | EP2025667A1 9,10-secopregnane derivative and pharmaceutical |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2025661A1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof |
| 02/18/2009 | EP2025354A1 Agent for preventing organ adhesion and method for preventing adhesion using the same |
| 02/18/2009 | EP2025347A1 Prophylactic and therapeutic agent for cancer |
| 02/18/2009 | EP2025341A1 Ointment for combating and treating skin diseases, and process for preparing said ointment |
| 02/18/2009 | EP2025339A1 WATER SOLUTION OF 20(R)-GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF |
| 02/18/2009 | EP2025338A1 New medicaments for the treatment of chronic ostructive pulmonary disease |
| 02/18/2009 | EP2025337A1 External pharmaceutical composition |
| 02/18/2009 | EP2025336A1 Retinyl derivatives for treating ophtalmic conditions |
| 02/18/2009 | EP2025335A1 Extracts with liver-X-receptor modulators, compounds and their use in weight control and treatment of disorders of lipid metabolism |
| 02/18/2009 | EP2025248A1 Cachexia prevention supplement |
| 02/18/2009 | EP2025058A2 Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis |
| 02/18/2009 | EP2024498A2 Protection against and treatment of age related macular degeneration |
| 02/18/2009 | EP2024385A1 Betulin derived compounds useful as antibacterial agents |
| 02/18/2009 | EP2024384A1 Betulin derived compounds useful as antiprotozoal agents |
| 02/18/2009 | EP2024383A2 Crystalline forms of 11 beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17alpha- hydroxy-19-nor-17 -pregna-4,9-dien-3-one |
| 02/18/2009 | EP2024380A2 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 02/18/2009 | EP2024379A1 New gem-difluoride c-glycoside compounds derived from podophyllotoxin, their preparation and applications |
| 02/18/2009 | EP2024376A1 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| 02/18/2009 | EP2024375A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 02/18/2009 | EP2024373A1 Tricyclic oxazepines as in vivo imaging compounds |
| 02/18/2009 | EP2024372A2 Thieno [3,2-d] pyrimidine derivative useful as pi3k inhibitor |
| 02/18/2009 | EP2024371A1 Phenanthrene derivatives as mpges-1 inhibitors |
| 02/18/2009 | EP2024370A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes |
| 02/18/2009 | EP2024368A2 6,7,8,9-tetrahydro-5h-pyrimido[4,5-d]azepin-4-yl]-amine derivatives as modulators of trpv1 for the treatment of pain |
| 02/18/2009 | EP2024367A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| 02/18/2009 | EP2024366A2 Monocyclic heteroaryl compounds |
| 02/18/2009 | EP2024365A2 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
| 02/18/2009 | EP2024364A1 Heterocyclic compounds as calcium channel blockers |
| 02/18/2009 | EP2024363A1 N-oxides of pyridylmethylpiperazine and -piperidine derivatives |
| 02/18/2009 | EP2024362A1 Iap bir domain binding compounds |